Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic
Market Cap
$29.86 Million
₹2.59 Billion INR
Market Cap Rank
#31901 Global
#1779 in India
Share Price
₹109.31
Change (1 day)
+4.99%
52-Week Range
₹72.00 - ₹192.44
All Time High
₹507.50
About

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences … Read more

Bafna Pharmaceuticals Limited (BAFNAPH) - Total Liabilities

Latest total liabilities as of September 2025: ₹694.55 Million INR

Based on the latest financial reports, Bafna Pharmaceuticals Limited (BAFNAPH) has total liabilities worth ₹694.55 Million INR as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Bafna Pharmaceuticals Limited - Total Liabilities Trend (2005–2025)

This chart illustrates how Bafna Pharmaceuticals Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Bafna Pharmaceuticals Limited Competitors by Total Liabilities

The table below lists competitors of Bafna Pharmaceuticals Limited ranked by their total liabilities.

Company Country Total Liabilities
PMVCD
PINK:PMVCD
USA $696.80K
New Concept Energy Inc
NYSE MKT:GBR
USA $63.00K
Entre Cua Socimi
MC:YENT
Spain €34.65 Million
Godha Cabcon & Insulation Limited
NSE:GODHA
India ₹-994.82 Million
Richmond Vanadium Technology Ltd
AU:RVT
Australia AU$1.23 Million
Trius Investments Inc
V:TRU
Canada CA$127.07K
Openn Negotiation Ltd
AU:OPN
Australia AU$131.18K

Liability Composition Analysis (2005–2025)

This chart breaks down Bafna Pharmaceuticals Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.67 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.76 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bafna Pharmaceuticals Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bafna Pharmaceuticals Limited (2005–2025)

The table below shows the annual total liabilities of Bafna Pharmaceuticals Limited from 2005 to 2025.

Year Total Liabilities Change
2025-03-31 ₹682.73 Million +2.14%
2024-03-31 ₹668.43 Million +19.09%
2023-03-31 ₹561.29 Million +99.17%
2022-03-31 ₹281.81 Million -5.10%
2021-03-31 ₹296.95 Million +47.61%
2020-03-31 ₹201.17 Million -80.01%
2019-03-31 ₹1.01 Billion -0.53%
2018-03-31 ₹1.01 Billion -25.72%
2017-03-31 ₹1.36 Billion +0.92%
2016-03-31 ₹1.35 Billion +6.17%
2015-03-31 ₹1.27 Billion -23.46%
2014-03-31 ₹1.66 Billion -13.63%
2013-03-31 ₹1.92 Billion +24.60%
2012-03-31 ₹1.54 Billion +89.51%
2011-03-31 ₹814.33 Million +88.84%
2010-03-31 ₹431.23 Million +9.71%
2009-03-31 ₹393.06 Million +0.09%
2008-03-31 ₹392.72 Million -12.47%
2007-03-31 ₹448.70 Million +184.28%
2006-03-31 ₹157.84 Million +25.31%
2005-03-31 ₹125.96 Million --